Next Article in Journal
Definitional Challenges in Understanding Hypertrophic Cardiomyopathy
Previous Article in Journal
Feasibility of Using 18F-FDG PET/CT Radiomics and Machine Learning to Detect Drug-Induced Interstitial Lung Disease
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Interesting Images

Natural History from Appendiceal Mucocele to Jelly Belly

1
1st Department of Surgery, General University Hospital Prague, 128 00 Prague, Czech Republic
2
1st Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic
3
Departments of Radiodiagnostics, General University Hospital Prague, 128 00 Prague, Czech Republic
*
Author to whom correspondence should be addressed.
Diagnostics 2024, 14(22), 2532; https://doi.org/10.3390/diagnostics14222532
Submission received: 8 October 2024 / Revised: 6 November 2024 / Accepted: 10 November 2024 / Published: 12 November 2024
(This article belongs to the Section Medical Imaging and Theranostics)

Abstract

:
Mucocele of the appendix and pseudomyxoma peritonei are rare diseases. The clinical findings are nonspecific in the early stages of the disease. The sequelae of appendiceal mucocele, its perforation, and extensive peritoneal involvement via pseudomyxoma peritonei (jelly belly) are repeatedly described in the literature. We present the typical findings in the natural history of the disease.

Pseudomyxoma peritonei is an extremely rare condition. Its incidence is about 1–4 cases/1 million/year [1,2,3,4]. There is a slightly higher incidence in females than in males (11:9) [5]. Most of these develop after a rupture of the appendicular mucocele. Appendicular mucoceles are uncommon with an incidence of about 0.2–0.7% of the population [4,6]. Progression to pseudomyxoma peritonei develops in 20% of patients [4]. Appendicular tumors (independent of histological findings) are found in 1% of all appendectomy specimens.
Appendiceal mucocele
Mucocele of the appendix refers to a dilated mucin-containing appendix. This term is mainly used by clinicians and radiologists (Figure 1, Figure 2, Figure 3 and Figure 4). It is necessary to distinguish “true mucocele” from a mucinous adenoid neoplasm [7]. The term mucocele was first used by Karl Freiherr von Rokitansky in 1842. Two years later, Werth used the term pseudomyxoma peritonei [4]. The clinical signs are minimal or often completely absent. The rupture of the mucocele can also be asymptomatic. Mucocele may be found on ultrasound or via a regular gynecological examination. A CT scan confirms the diagnosis. Treatment consists of the surgical removal of the dilated appendix, often together with the surrounding part of the cecum (Figure 5, Figure 6 and Figure 7). This approach is curative if there is no rupture or presence of tumor cells on the peritoneal surface. The diagnosis is confirmed through pathological examination of the specimen (Figure 8).
Pseudomyxoma peritonei
Pseudomyxoma peritonei is a clinical diagnosis characterized by the accumulation of mucinous masses inside the abdominal cavity. It occurs as a result of a rupture of the appendiceal mucocele. The progression from mucocele to pseudomyxoma usually takes several years.
Mucinous implantation and accumulation lead to abdominal distension, discomfort, pain, and bowel obstruction. A palpable mass in the abdomen is a late symptom [4]. The localization of mucin and a tumor is characterized by the phenomenon of redistribution [8]. This means that the tumor cells move with the intra-abdominal fluid and also according to gravity. The highest concentration is at the gravity gradient sites and then at the sites of fluid absorption from the abdominal cavity.
The treatment for pseudomyxoma peritonei is based on the Sugarbaker technique of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC), sometimes followed by early postoperative intraperitoneal chemotherapy (EPIC) for five days. The results of this treatment are very favorable. The 5-year survival rate predicted via the Kaplan–Meier method is over 80% [8].
In this article, we show the natural history of the disease and the typical findings at the different stages of this rare diagnosis.
Figure 1. Mucocele of the appendix (arrow) (CT, venous phase, sagittal plane). There is cystic dilatation of the appendix behind the ascending colon. There is no evidence of perforation or the presence of mucin outside the mucocele.
Figure 1. Mucocele of the appendix (arrow) (CT, venous phase, sagittal plane). There is cystic dilatation of the appendix behind the ascending colon. There is no evidence of perforation or the presence of mucin outside the mucocele.
Diagnostics 14 02532 g001
Figure 2. Mucocele of the appendix with calcification in the mucocele’s wall (arrows) (CT, venous phase, sagittal plane). Cystic dilatation of the appendix and calcification in the appendiceal wall. This is a typical sign for a mucocele, and it is present in 50% of patients [9].
Figure 2. Mucocele of the appendix with calcification in the mucocele’s wall (arrows) (CT, venous phase, sagittal plane). Cystic dilatation of the appendix and calcification in the appendiceal wall. This is a typical sign for a mucocele, and it is present in 50% of patients [9].
Diagnostics 14 02532 g002
Figure 3. Another example of an appendiceal mucocele with calcification in the wall (arrow) (CT, venous phase, axial plane).
Figure 3. Another example of an appendiceal mucocele with calcification in the wall (arrow) (CT, venous phase, axial plane).
Diagnostics 14 02532 g003
Figure 4. Cystic dilatation of the appendix (mucocele) (arrow) (MRI, axial plane).
Figure 4. Cystic dilatation of the appendix (mucocele) (arrow) (MRI, axial plane).
Diagnostics 14 02532 g004
Figure 5. Mucocele of the appendix without perforation during laparoscopic surgery. There is a partial dilatation of the appendix and a healthy appendicular base.
Figure 5. Mucocele of the appendix without perforation during laparoscopic surgery. There is a partial dilatation of the appendix and a healthy appendicular base.
Diagnostics 14 02532 g005
Figure 6. Radical appendectomy including appendiceal mesentery and cecal bases with linear stapler.
Figure 6. Radical appendectomy including appendiceal mesentery and cecal bases with linear stapler.
Diagnostics 14 02532 g006
Figure 7. The specimen.
Figure 7. The specimen.
Diagnostics 14 02532 g007
Figure 8. Pathological specimen (40×). The wall of the appendix is intact, there is no sign of perforation and no signs of malignancy, and mucin is only in the appendicle lumen.
Figure 8. Pathological specimen (40×). The wall of the appendix is intact, there is no sign of perforation and no signs of malignancy, and mucin is only in the appendicle lumen.
Diagnostics 14 02532 g008
The mucocele ruptures due to increased intra-appendicular pressure, releasing mucus and tumor cells into the peritoneal cavity (Figure 9 and Figure 10). The rupture may be asymptomatic or associated with only mild and nonspecific clinical signs. Typical peritoneal signs and bacterial peritonitis are usually absent because the communication to the lumen of the colon is closed by mucin. Treatment in these cases is called a radical appendectomy, with the resection of the cecal bases, but without a right colectomy. The addition of HIPEC is fully indicated. It is necessary to examine the whole abdomen to exclude the presence of tumors in typical locations, such as the Douglas pouch and the undersurfaces of the diaphragm and the right and left paracolic gutter.
The current pathophysiological mechanism is based on the Sugarbaker theory. The adenoma forms in the lumen of the appendix, and as it grows, the lumen becomes occluded. As a result of this occlusion, a distended part of the appendix dilates, and the wall of the appendix ruptures. The mucous membrane and epithelial cells from the adenoma are then released and shed into the abdominal cavity [8].
Patients with a misdiagnosed rupture of the mucocele may develop pseudomyxoma peritonei. It is characterized by the presence of an abundant gelatinous substance in the abdomen. Diffuse, progressive, and abundant mucin-containing tumor cells are typical of this disease [2] (Figure 11, Figure 12, Figure 13, Figure 14, Figure 15 and Figure 16). The interval between rupture and advanced disease is several years. In our clinical series, the interval was about 5 years. In the literature, we found a wide range of this interval from 12 months to 10 years [9,10]. The natural history of PMP revolves around the “redistribution phenomenon”, whereby mucinous tumor cells accumulate in the Douglas pouch, in the diaphragm (more on the right), and the small and large omentum (Figure 17). The small intestine is less involved [4]. Pseudomyxoma peritonei is a slowly progressing disease, which fills the peritoneal cavity over time. There are several classifications of pseudomyxoma. The most commonly used is the PSOGI classification [2]. Mucinous accumulation progresses to malnutrition, bowel obstruction, and respiratory compromise. Rarely, the tumor may spread to the pleural cavity. This has been described in 5.4% of cases. It may occur spontaneously or as a result of diaphragmatic injury during cytoreduction [8,11].
Figure 11, Figure 12, Figure 13, Figure 14 and Figure 15. Advanced stage of the disease. The abdomen is full of tumors and mucin. Typical signs are heterogeneous or hypodense masses in the form of lobules often with septa, which could be enhanced by contrast and could be associated with calcifications.
Treatment of the advanced disease consists of maximal cytoreduction (Figure 18 and Figure 19), which means the removal of all visible tumors and HIPEC. The abdominal cavity is lavaged with a warmed cytostatic solution at 42 degrees Celsius for 90 min. The most commonly used cytostatic is mitomycin. The clinical classification of pseudomyxoma peritonei is based on the Sugarbaker peritoneal cancer index, which can stratify the extent of the disease. The radicality of surgery is assessed according to the cytoreduction score [3,8,12].
Patients who have undergone cytoreductive surgery and HIPEC due to pseudomyxoma peritonei should be followed up with imaging studies at regular intervals. Recurrence may occur after several years (Figure 20 and Figure 21).
Conclusions
Pseudomyxoma peritonei is a rare disease that occurs as a result of perforation of the appendiceal mucocele, which is also rare. It is necessary to know the typical clinical, imaging, and operative findings. The treatment follows the recommendations of PSOGI. Overtreatment should be avoided in the case of uncomplicated findings without perforation; on the other hand, early referral of patients with a perforated mucocele to a center with the possibility of HIPEC treatment will prevent extensive disease.
In this article, we showed the typical findings in the early and advanced stages of the disease. A limitation is the wide clinical variability, especially during disease progression, where not all possibilities can be covered herein.

Author Contributions

Conceptualization, D.H. and P.D.; methodology, D.H., P.D. and S.S.; investigation, M.L., P.K., A.P. and A.B.; resources, M.L. and A.P.; writing—original draft preparation, D.H., M.L. and S.S.; writing—review and editing, P.D. and P.K.; supervision, Z.K.; funding acquisition, Z.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Ministry of Health, Czech Republic—Conceptual Development of Research Organization 00064165, General University Hospital in Prague, and by the Cooperatio Program, Research Area Surgical Disciplines, Abdominal Surgery.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of General University Hospital Prague protocol code 51/21, 16. 9. 2021.

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study. Written informed consent has been obtained from the patient(s) to publish this paper.

Data Availability Statement

No new data were created or analyzed in this study.

Acknowledgments

Pavel Dundr, Department of Pathology, for photographs of the microscope slides.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Ye, S.; Zheng, S. Comprehensive Understanding and Evolutional Therapeutic Schemes for Pseudomyxoma Peritonei: A Literature Review. Am. J. Clin. Oncol. 2022, 45, 223–231. [Google Scholar] [CrossRef] [PubMed]
  2. Lin, Y.-L.; Xu, D.-Z.; Li, X.-B.; Yan, F.-C.; Xu, H.-B.; Peng, Z.; Li, Y. Consensuses and Controversies on Pseudomyxoma Peritonei: A Review of the Published Consensus Statements and Guidelines. Orphanet J. Rare Dis. 2021, 16, 85. [Google Scholar] [CrossRef] [PubMed]
  3. Govaerts, K.; Lurvink, R.J.; De Hingh, I.H.J.T.; Van Der Speeten, K.; Villeneuve, L.; Kusamura, S.; Kepenekian, V.; Deraco, M.; Glehen, O.; Moran, B.J.; et al. Appendiceal Tumours and Pseudomyxoma Peritonei: Literature Review with PSOGI/EURACAN Clinical Practice Guidelines for Diagnosis and Treatment. Eur. J. Surg. Oncol. 2021, 47, 11–35. [Google Scholar] [CrossRef] [PubMed]
  4. Mittal, R.; Chandramohan, A.; Moran, B. Pseudomyxoma Peritonei: Natural History and Treatment. Int. J. Hyperth. 2017, 33, 511–519. [Google Scholar] [CrossRef] [PubMed]
  5. Garg, P.; Garg, N.; Peer, S.; Chholak, D.; Kaur, M. Pseudomyxoma Peritonei Leading to “Jelly Belly” Abdomen: A Case Report and Review of the Literature. J. Med. Case Rep. 2024, 18, 296. [Google Scholar] [CrossRef] [PubMed]
  6. Oyeh, E.; Nsaful, J.; Bediako-Bowan, A.; Gbadamosi, H.; Boateng Mensah, Y.; Adu-Aryee, N.A.; Nyarko, V. Mucocoele of the Appendix. Ghana Med. J. 2024, 58, 109–114. [Google Scholar] [CrossRef] [PubMed]
  7. Sakata, S.; Moran, B.J. What Is a ‘Mucocele’ of the Appendix and How Are These Lesions Best Managed? Beware the Wolf in Sheep’s Clothing. Color. Dis. 2019, 21, 1237–1239. [Google Scholar] [CrossRef] [PubMed]
  8. Esquivel, J.; Sugarbaker, P.H. Clinical Presentation of the Pseudomyxoma Peritonei Syndrome. J. Br. Surg. 2000, 87, 1414–1418. [Google Scholar] [CrossRef] [PubMed]
  9. Spyropoulos, C.; Rentis, A.; Alexaki, E.; Triantafillidis, J.K.; Vagianos, C. Appendiceal Mucocele and Pseudomyxoma Peritonei; The Clinical Boundaries of a Subtle Disease. Am. J. Case Rep. 2014, 15, 355–360. [Google Scholar] [CrossRef] [PubMed]
  10. Da Fonseca, L.M.; Lacerda-Filho, A.; da Silva, R.G. Pseudomyxoma Peritonei Syndrome 12 Months after an Intact Resection of Malignant Mucocele of the Appendix: A Case Report. Clinics 2010, 65, 817–818. [Google Scholar] [CrossRef] [PubMed]
  11. Pestieau, S.R.; Esquivel, J.; Sugarbaker, P.H. Pleural Extension of Mucinous Tumor in Patients with Pseudomyxoma Peritonei Syndrome. Ann. Surg. Oncol. 2000, 7, 199–203. [Google Scholar] [CrossRef] [PubMed]
  12. Hoskovec, D.; Varga, J.; Konečná, E.; Antoš, F. Levels of CEA and Ca 19-9 in the Sera and Peritoneal Cavity in Patients with Gastric and Pancreatic Cancers. Acta Cir. Bras. 2012, 27, 410–416. [Google Scholar] [CrossRef] [PubMed]
Figure 9. Ruptured mucocele of the appendix (a), with free mucin around the appendix (b) (CT, venous phase, axial plane).
Figure 9. Ruptured mucocele of the appendix (a), with free mucin around the appendix (b) (CT, venous phase, axial plane).
Diagnostics 14 02532 g009
Figure 10. Ruptured mucocele of the appendix in perioperative view. Part of the appendix (black arrow) is embedded in mucus (white arrow), which covers the perforation.
Figure 10. Ruptured mucocele of the appendix in perioperative view. Part of the appendix (black arrow) is embedded in mucus (white arrow), which covers the perforation.
Diagnostics 14 02532 g010
Figure 11. CT, venous phase, axial plane.
Figure 11. CT, venous phase, axial plane.
Diagnostics 14 02532 g011
Figure 12. CT, venous phase, coronar plane.
Figure 12. CT, venous phase, coronar plane.
Diagnostics 14 02532 g012
Figure 13. CT, venous phase, axial plane.
Figure 13. CT, venous phase, axial plane.
Diagnostics 14 02532 g013
Figure 14. CT, venous phase, coronar plane.
Figure 14. CT, venous phase, coronar plane.
Diagnostics 14 02532 g014
Figure 15. CT, venous phase, sagittal plane.
Figure 15. CT, venous phase, sagittal plane.
Diagnostics 14 02532 g015
Figure 16. Distended abdomen due to a large accumulation of mucin and tumorous masses.
Figure 16. Distended abdomen due to a large accumulation of mucin and tumorous masses.
Diagnostics 14 02532 g016
Figure 17. Intraoperative view of the abdominal cavity. The omentum contains many tumors.
Figure 17. Intraoperative view of the abdominal cavity. The omentum contains many tumors.
Diagnostics 14 02532 g017
Figure 18. Specimen with tumor (black arrows) and mucin (white arrows).
Figure 18. Specimen with tumor (black arrows) and mucin (white arrows).
Diagnostics 14 02532 g018
Figure 19. The diaphragm after removing the peritoneum with tumors.
Figure 19. The diaphragm after removing the peritoneum with tumors.
Diagnostics 14 02532 g019
Figure 20. Recurrence four years after CRS + HIPEC. Mucinous tumor around the liver and in the porta hepatis (arrows). This patient was successfully treated with repeated CRS + HIPEC. (CT, portal phase, coronar plane).
Figure 20. Recurrence four years after CRS + HIPEC. Mucinous tumor around the liver and in the porta hepatis (arrows). This patient was successfully treated with repeated CRS + HIPEC. (CT, portal phase, coronar plane).
Diagnostics 14 02532 g020
Figure 21. Recurrence of the pseudomyxoma peritonei in the abdominal and left thoracic cavities (arrows). The patient underwent two operations: first, CRS + HIPEC to address the intra-abdominal disease; then, CRS + HITHOC in the left thoracic cavity. The cause of the spread of the disease to the chest would probably be a thermal lesion of the diaphragm, which manifested sometime after the primary surgery. (CT, venous phase, coronar plane).
Figure 21. Recurrence of the pseudomyxoma peritonei in the abdominal and left thoracic cavities (arrows). The patient underwent two operations: first, CRS + HIPEC to address the intra-abdominal disease; then, CRS + HITHOC in the left thoracic cavity. The cause of the spread of the disease to the chest would probably be a thermal lesion of the diaphragm, which manifested sometime after the primary surgery. (CT, venous phase, coronar plane).
Diagnostics 14 02532 g021
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Hoskovec, D.; Krška, Z.; Pudlač, A.; Lochman, M.; Strohalmová, S.; Bocán, A.; Koželský, P.; Dytrych, P. Natural History from Appendiceal Mucocele to Jelly Belly. Diagnostics 2024, 14, 2532. https://doi.org/10.3390/diagnostics14222532

AMA Style

Hoskovec D, Krška Z, Pudlač A, Lochman M, Strohalmová S, Bocán A, Koželský P, Dytrych P. Natural History from Appendiceal Mucocele to Jelly Belly. Diagnostics. 2024; 14(22):2532. https://doi.org/10.3390/diagnostics14222532

Chicago/Turabian Style

Hoskovec, David, Zdeněk Krška, Adam Pudlač, Matyáš Lochman, Sabina Strohalmová, Andrej Bocán, Pavel Koželský, and Petr Dytrych. 2024. "Natural History from Appendiceal Mucocele to Jelly Belly" Diagnostics 14, no. 22: 2532. https://doi.org/10.3390/diagnostics14222532

APA Style

Hoskovec, D., Krška, Z., Pudlač, A., Lochman, M., Strohalmová, S., Bocán, A., Koželský, P., & Dytrych, P. (2024). Natural History from Appendiceal Mucocele to Jelly Belly. Diagnostics, 14(22), 2532. https://doi.org/10.3390/diagnostics14222532

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop